Zolpidem Tartrate
Product manufactured by Bryant Ranch Prepack
Indications and Purposes
1 Indications And Usage Zolpidem Tartrate Extended-Release Tablet, A Gamma-Aminobutyric Acid (gaba) A Receptor Positive Modulator, Is Indicated For The Treatment Of Insomnia Characterized By Difficulties With Sleep Onset And/or Sleep Maintenance. ( 1 ) Zolpidem Tartrate Extended-Release Tablets Are Indicated For The Treatment Of Insomnia Characterized By Difficulties With Sleep Onset And/or Sleep Maintenance (as Measured By Wake Time After Sleep Onset). The Clinical Trials Performed In Support Of Efficacy Were Up To 3 Weeks (using Polysomnography Measurement Up To 2 Weeks In Both Adult And Elderly Patients) And 24 Weeks (using Patient-Reported Assessment In Adult Patients Only) In Duration [see Clinical Studies ( 14 )]. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
Name | Structure | ZINC ID(s) |
---|---|---|
1. Zolpidem Tartrate | ZINC3876 |